Loading ...

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

Based on

1 Patents
2011 Most recent source

Composition

1

3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride

nifedipine hydrochloride Nif hydrochloride nifedipine
Type Single Compound
Formula C17H18N2O6
Role core
2

hexadecyltrimethylammonium bromide

cetyltrimethylammonium bromide cetrimonium bromide CTAB
Type Single Compound
Formula C19H42BrN
Role layer

Properties

General physical and chemical properties

Property Value Nanomaterial Variant Source
Zeta potential

More information/entries available to subscribers only.

Or, view sample content

Characterization

Method Nanomaterial Variant Source
scanning electron microscopy

More information available to subscribers only.

Or, view sample content

Preparation

Method 1

Type: Chemical synthesis
Source:
Starting materials
  • 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
  • hexadecyltrimethylammonium bromide
  1. 33N4MKSDfOECpRekD5MHwSvfkW
Product

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

Diameter: 480 - 2373 nm

Medium/Support: none

Method 2

Type: Chemical synthesis
Source:
Starting materials
  • 3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride
  • hexadecyltrimethylammonium bromide
  1. tPRnJHdQd9hDTuUQSR
Product

cetyltrimethylammonium bromide-coated nifedipine nanoparticles

Diameter: 480 - 2373 nm

Medium/Support: none

References

Full content is available to subscribers only

To view content please choose from the following:


Sign up for a free trial